INFORMAZIONI SU QUESTO ARTICOLO

Cita

1. BALMASOVA IP, YUSHCHUK ND, MINBAEV OA, ALLA NR, MALOVA ES, ZHONG JE, SHI Z, GAO CI. Immunopathogenesis of chronic hepatitis. World J. Gastroenterol. 2014, 20, 39, 14156-14171.Search in Google Scholar

2. TREPOC CHAN HL, LOK A. Hepatitis B virus infection. Lancet. 2014, 384, 9959, 2053-2063.Search in Google Scholar

3. LIU XR, SHEN YH. Membranous glomerulopathy associated with hepatitis B virus infection. HKig Pediatr (newseries), 2002, 13, 22-29.Search in Google Scholar

4. VENKATASESHAN VS, LIEBERMAN K, KIM DU, THUNG S, DIUMAN S. Hepatitis B associated glomerulonephritis: pathology, pathogenesis and clinical course. Medicine (Baltimore) 1990, 69, 4, 200-216.10.1097/00005792-199007000-00002Search in Google Scholar

5. ZHANG JH, LI ZHOU N. Is there a hepatitis B virus-assocated glomerulonephritis? Identification of HBsAg, HBc and HBcAg with monoclonal antibodies. Chin. Med. J. (Engl)1989, 108, 7, 496-504.Search in Google Scholar

6. LIN CY, LIN CS, CHANG GH. Defect of cell mediated immune response against hepatitis;an indication for pathogenesis of hepatitis B virus-associated membranous nephropathy. Nephron 1994 ,765,176-185.10.1159/0001901669200409Search in Google Scholar

7. PENG G, Li S, WU W, SUN Z, CHEN Y, CHEN Z. Circulating CD4+CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology. 2008, 123, 57-65.Search in Google Scholar

8. LU H, ZHU H, ZHOU Y. S gene mutation of HBV in children with HBV-associated glomerulonephritis. Virol. J. 2012, 9, 59, doi 10.IV 86/1743/422Y-9-5.Search in Google Scholar

9. HUI D, YAN V, WEI Y, RUIXIZ M, GUANGIU G. Significance of mutations in hepatitis B virus X gene for pathogenesis HBV-associated glomerulonephritis. Acta Virol. 2014, 58, 3, 278-281.Search in Google Scholar

10. LAI KH, HO RT, TAM JS, LAI FM. Detection of hepatitis B virus DNA and RNA in kidney of HBV related glomerulonephritis. Kidney Int. 1996, 50, 6, 1965-1997.Search in Google Scholar

11. El-SERAQ HR, HAMPEL H, YEH E. RABENECK I. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002, 36, 6, 1439-1445.10.1002/hep.1840360621Search in Google Scholar

12. MOE SM, PAMPALONE A, OFNER S, ROSEMAN M, TED E, HUI SL. Association of hepatitis C virus infection with prevalence and development of kidney diseases. Am J. Kidney Dis 2008, 51, 6, 885-892.10.1053/j.ajkd.2008.03.009247874218440680Search in Google Scholar

13. FABRIZI F, MARTIN P, DIXIT V, MESSA P. Hepatitis virus infection and kidney disease: a meta analysis. Clin J. Am Soc Nephrol. 2012, 7, 4, 549-557.Search in Google Scholar

14. CHARTER Ed, DUSTIN LB. Hepatitis C virus-induced cryoglobulinaemia. Kidney Int 2009, 76, 8, 818-824.10.1038/ki.2009.247275559819606079Search in Google Scholar

15. FABRIZI F, MESSA P, MARTIN P. Novel evidence on hepatitis C virus-associated glomerular disease. Kidney Int. 2014, 86, 3, 466-469.Search in Google Scholar

16. TANA MM, HELLER T. Autoantibodies in hepatitis C: red flag or bystander. J Pediat Gastroenterol. Nutr. 2013, 56, 3, 243.Search in Google Scholar

17. FERRY S, MURATORI L, LENZI M. HCV and auto immunity. Curr. Pharm. Dis 2008, 14, 1672-1685 (Pub Med).10.2174/13816120878474682418673191Search in Google Scholar

18. MARCEAU G, LAPIERRE P, BELAND K, SAUDEYENS H, ALVAREZ F. LKM and autoantibodies in chronic hepatitis C infections. A case of molecular mimicry? Hepatology 2005, 42, 675-682.10.1002/hep.2081616037945Search in Google Scholar

19. STOKES MB. Immune complex glomerulonephritis in patients with hepatitis C. Saudi J Kidney Dis Transpl (Serial Online). 2000, 11, 3, 396-404.Search in Google Scholar

20. HO V, CHEN J. Hepatitis XC virus associated glomerulonephritis in: PRZONACAR S, An update on glomerulonephritis. Clinical and treatment aspects. 2011. In tech Shanghai, China.10.5772/24800Search in Google Scholar

21. ISKANDAR SS, HERRERA GA. Glomerulopathies with organized deposits. Semin Diagn Pathol 2002, 19, 3, 116-132.Search in Google Scholar

22. SANSANNO D, LAULETTA G, MONTRONE M, GRANDALIANO G, SCHENA FP, DAMMACCO F. Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol 2005, 140, 3, 498-506.10.1111/j.1365-2249.2005.02778.x180938115932511Search in Google Scholar

23. CAO Y, ZHANG Y, WANG S, ZOU W. Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis. Nephrol Dial Transplant. 2009; 24, 9, 2745-2751.Search in Google Scholar

24. KONG D, WU D, VAN T, LI T, ZU S, CHEN F, KIN X, LOU C. Detection of viral antigens in renal tissue of glomerulonephritis patients without serological evidence of hepatitis B virus and hepatitis C virus infection. Int. J. Infect Dis 2013, 17, 7, e 535-e538.10.1016/j.ijid.2013.01.01723474175Search in Google Scholar

25. WHO. Hepatitis C. Fact sheet update. April 2014.Search in Google Scholar

26. JOHNSON RJ, GRETCH DR, COUSER WG, ALPERS CE, WILSON J, CHUNG N et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl. J. Med 1993, 328, 7, 465-470.10.1056/NEJM1993021832807037678440Search in Google Scholar

27. QUARTUCCIO L, SOARDO GE, ROMANO G, SCOTT CA, De MARCHE G et al. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia; efficacy and safety in the absence of steroids. Rheumatology, 2006, 45, 7, 842-846.10.1093/rheumatology/kel00416418196Search in Google Scholar

28. HO V, CHEN J. Hepatitis C virus associated glomerulonephritis in: PRABHAKAR SEd. An update on glomerulopathies. Clinical and treatment aspects 2011. In: Tech Shanghai, China.10.5772/24800Search in Google Scholar

29. SUGIMOTO K, TAKEI. Clinicopathological features of non-alcoholic fatty liver disease. Hepatol Res 2011, 10, 911-920.10.1111/j.1872-034X.2011.00867.x21951869Search in Google Scholar

30. AHN AL, CHOI JK, KIM MN, KIM SA, OH EJ, KUCON HJ, CHO DY. Non-alcoholic fatty liver disease and chronic liver disease in Koreans aged 50 years or older. Korean J. Fam Med. 2013, 34, 3, 199-205.Search in Google Scholar

31. SIROTA JC, McFANN K, TARGHER G, CHONCHOL M, JALAL DI. Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988-1994. Am J Nephrol. 2012, 36, 5, 466-71. doi: 10.1159/000343885.10.1159/000343885356328723128368Search in Google Scholar

32. TARGER G, CHONCHOL M, ZOPPINI G, ABATERUSSO C, DONORA E. Risk of chronic kidney disease in patients with non-alcholic fatty disease. Is there a link ? J Hepatol 2011, 54, 5, 1020-1029.10.1016/j.jhep.2010.11.00721145850Search in Google Scholar

33. MUSSO G, GAMBINO R, TABIBIAN JH. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. Plos Med. 2014, 11, 7: e 1001680 doi 10.1374/journal p med 1001680 e collection 2014.Search in Google Scholar

34. BULUM T, DUVNJAK L. Relationship between nonalcoholic fatty liver disease markers and renal function in patients with type 1 diabetes. Acta Med Croatia 2011, 65, Supp l, 3, 6-10, Pub Med.Search in Google Scholar

35. YILMAZ Y, ALAHDAB Y, YONAL O. Microalbuminuria in non-diabetic patients with nonalcoholic fatty liver disease associated with liver fibrosis. Metabolism 2010, 59, 9, 1327-1330.10.1016/j.metabol.2009.12.01220096896Search in Google Scholar

36. ADHIKARI KB, OREN T. Non-alcoholic fatty liver disease (NAFLD) and immune response. J Inst Med 2010, 3, 43-53.10.3126/jiom.v32i3.4960Search in Google Scholar

37. IX JH, SHARMA K. Mechanisms linking obesity, chronic kidney disease and fatty liver disease, the role of fetuin A, adiponectin and AMPK. J Am Soc Nephrol 2010, 21, 3, 406-412.10.1681/ASN.2009080820447325420150538Search in Google Scholar

38. MOURALIDANE A, SOEDA J, VISCONTI-PUGMIRE, SAMULELSON A, TOMBO J, MARAGKOUDAKI X. Maternal obesity programs offspring non-alcoholic fatty liver disease via innate immune disjunction in mice. Hepatology 2013, 52, 128-138.10.1002/hep.2624823315950Search in Google Scholar

39. AMOR J, CHABO C, WAGET A, KLOPP P, VACHOU C, BEMUDEZ-HUNARAN LG. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes, molecular mechanisms and probiotic treatment. EMBO, Mol Med. 2011, 3, 559-572.Search in Google Scholar

40. MELI R, RASO GM, CALIGNANO A. Role of innate response in non-alcoholic fatty liver disease: metabolic complications and therapeutic tools. Front Immunol 2014/doi: 103389/ fimmu 2014-00177.10.3389/fimmu.2014.00177400596524795720Search in Google Scholar

41. ORLIC I, MIKOLASEVIC I, BAGIC Z, RACUL S, STIMAC D MILIC. Chronic kidney disease and non-alcoholic liver disease - is there a link? Gastroenterol. Res. Pract. 2014, doi org/10-1155/2014/847539.10.1155/2014/847539396336624729784Search in Google Scholar

42. JIN K, NORIS K, VAZIRI ND. Dysregulation of hepatic fatty acid metabolism in chronic kidney disease. Nephrol Dial Transplant. 2013, 28, 2, 313-320.Search in Google Scholar

43. YANG M, GONG S, YE SQ, LYMAN B, CHEN P, DY L. Non-alcoholic fatty liver disease in children: focus on nutritional interventions. Nutrients 2014, 6, 1, 4691-4705.10.3390/nu6114691424555725353664Search in Google Scholar

44. NEWELL CC. Cirrhotic glomerulonephritis, incidence, morphology, clinical features and pathogenesis. Am. J. Kidney Dis. 1987, 9, 3, 183-190.Search in Google Scholar

45. POURIS S, FEEHALLY J. Glomerular IgA deposition in liver disease. Nephrol Dial Transplant, 199, 14, 10, 2279-2282.10.1093/ndt/14.10.227910528642Search in Google Scholar

46. TISSANDIE E, MORELLE W, BERTHELOT L, VRTOVSNIK F, DAUGAS M et al. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89 -IgA complexes common mechanisms for distinct disease. Kidney Int 2011, 80, 12, 1352-1363.10.1038/ki.2011.27621866091Search in Google Scholar

47. KALAMBOKIS G, CRISTOU I, STEFANOU D, ARKEUMANI E, TSIANOS EV. Association of liver cirrhosis related IgA nephropathy with portal hypertension. World J Gastroenterol, 2017, 13 13, 43, 5783-5786. 10.3748/wjg.v13.i43.5783417127117963311Search in Google Scholar

eISSN:
1220-4749
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicine, Clinical Medicine, Internal Medicine, other, Cardiology, Gastroenterology, Rheumatology